Department of Medical Physics, The Oklahoma Proton Center, Oklahoma City, Oklahoma, USA.
Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida, USA.
J Appl Clin Med Phys. 2021 Jul;22(7):147-154. doi: 10.1002/acm2.13293. Epub 2021 Jun 7.
The purpose of the current study was threefold: (a) investigate the impact of the variations (errors) in spot sizes in robustly optimized pencil beam scanning (PBS) proton-based stereotactic body radiation therapy (SBRT) lung plans, (b) evaluate the impact of spot sizes and position errors simultaneously, and (c) assess the overall effect of spot size and position errors occurring simultaneously in conjunction with either setup or range errors.
In this retrospective study, computed tomography (CT) data set of five lung patients was selected. Treatment plans were regenerated for a total dose of 5000 cGy(RBE) in 5 fractions using a single-field optimization (SFO) technique. Monte Carlo was used for the plan optimization and final dose calculations. Nominal plans were normalized such that 99% of the clinical target volume (CTV) received the prescription dose. The analysis was divided into three groups. Group 1: The increasing and decreasing spot sizes were evaluated for ±10%, ±15%, and ±20% errors. Group 2: Errors in spot size and spot positions were evaluated simultaneously (spot size: ±10%; spot position: ±1 and ±2 mm). Group 3: Simulated plans from Group 2 were evaluated for the setup (±5 mm) and range (±3.5%) errors.
Group 1: For the spot size errors of ±10%, the average reduction in D for -10% and +10% errors was 0.7% and 1.1%, respectively. For -15% and +15% spot size errors, the average reduction in D was 1.4% and 1.9%, respectively. The average reduction in D was 2.1% for -20% error and 2.8% for +20% error. The hot spot evaluation showed that, for the same magnitude of error, the decreasing spot sizes resulted in a positive difference (hotter plan) when compared with the increasing spot sizes. Group 2: For a 10% increase in spot size in conjunction with a -1 mm (+1 mm) shift in spot position, the average reduction in D was 1.5% (1.8%). For a 10% decrease in spot size in conjunction with a -1 mm (+1 mm) shift in spot position, the reduction in D was 0.8% (0.9%). For the spot size errors of ±10% and spot position errors of ±2 mm, the average reduction in D was 2.4%. Group 3: Based on the results from 160 plans (4 plans for spot size [±10%] and position [±1 mm] errors × 8 scenarios × 5 patients), the average D was 4748 cGy(RBE) with the average reduction of 5.0%. The isocentric shift in the superior-inferior direction yielded the least homogenous dose distributions inside the target volume.
The increasing spot sizes resulted in decreased target coverage and dose homogeneity. Similarly, the decreasing spot sizes led to a loss of target coverage, overdosage, and degradation of dose homogeneity. The addition of spot size and position errors to plan robustness parameters (setup and range uncertainties) increased the target coverage loss and decreased the dose homogeneity.
本研究旨在实现三个目标:(a) 研究稳健优化笔形束扫描(PBS)质子立体定向体放射治疗(SBRT)肺计划中射野内剂量点大小(误差)变化的影响;(b) 同时评估点大小和位置误差的影响;(c) 评估同时发生的点大小和位置误差与设置或范围误差联合发生的总体影响。
在这项回顾性研究中,选择了五名肺癌患者的计算机断层扫描(CT)数据集。使用单野优化(SFO)技术,为总剂量 5000 cGy(RBE)的 5 个分数再生治疗计划。使用蒙特卡罗方法进行计划优化和最终剂量计算。名义计划归一化为使 99%的临床靶体积(CTV)接受处方剂量。分析分为三组。第 1 组:评估 +/-10%、 +/-15%和 +/-20%的点大小增加和减少误差。第 2 组:同时评估点大小和点位置误差(点大小: +/-10%;点位置: +/-1 和 +/-2 mm)。第 3 组:对来自第 2 组的模拟计划评估设置( +/-5 mm)和范围( +/-3.5%)误差。
第 1 组:对于 +/-10%的点大小误差,-10%和 +10%误差的 D 平均值分别降低了 0.7%和 1.1%。对于-15%和+15%的点大小误差,D 的平均降低分别为 1.4%和 1.9%。-20%误差时 D 的平均降低为 2.1%,+20%误差时 D 的平均降低为 2.8%。热点评估表明,对于相同大小的误差,与增加点大小相比,减小点大小会导致正差异(更热的计划)。第 2 组:点大小增加 10%,同时点位置向-1 mm(+1 mm)移动,D 的平均降低为 1.5%(1.8%)。点大小减小 10%,同时点位置向-1 mm(+1 mm)移动,D 的降低为 0.8%(0.9%)。点大小误差为 +/-10%,点位置误差为 +/-2 mm,D 的平均降低为 2.4%。第 3 组:基于 160 个计划的结果(点大小[ +/-10%]和位置[ +/-1 mm]误差各 4 个方案 x 8 个场景 x 5 个患者),平均 D 为 4748 cGy(RBE),平均降低 5.0%。等中心在上下方向的移位导致靶区内的剂量分布最不均匀。
增加点大小会导致靶区覆盖率和剂量均匀性降低。同样,减小点大小会导致靶区覆盖率降低、过度照射和剂量均匀性恶化。将点大小和位置误差添加到计划稳健性参数(设置和范围不确定性)中会增加靶区覆盖率损失并降低剂量均匀性。